Ultra-Sensitivity
With 10,000x sensitivity compared to PCR or NGS, LiquiDyne provides single EV-level cancer resistance markers.
1-Day Turnaround Time
Without any need for pretreatment, LiquiDyne can yield results within
1 day upon receipt of blood plasma.
Cloud-based Longitudinal Monitoring
Medical professionals can access results instantly and collect patient data over time in one place.
Multi-Mutation Tests
With multiplexing, LiquiDyne Longitude can monitor multiple mutations in one.
1-Day Turnaround Time
Unparallelled Sensitivity and Specificity
LiquiDyne provided unprecedented level of sensitivity and specificity in
detecting cancer mutations through blood biopsy.
Blood Plasma Testing
with No Pretreatment
LilquiDyne does not need lengthy preparation process that cause sample losses.
Sensitive Resistance Marker Detection
During treatment, LiquiDyne can detect resistance mutation developments with unprecedented sensitivity, enabling timely treatment decision making.
Longitudinal Data,
in One Place
Through LiquiDyne Cloud, medical professionals can securely collect longitudinal data over time and view them in one place.
